Cognex Q3 2026 Earnings: Record Revenue Drives Margin Expansion
Cognex reported Q3 2026 revenue of $313.4 million, up 13% year over year, with GAAP diluted EPS rising to $0.50. Strong pricing execution, favorable product mix, and reduced operating expenses drove GAAP operating margin to 32.2% and free cash flow to $103.8 million. Backed by these results, management raised its full-year guidance. Key risks and monitoring items include an expected sequential revenue decline in Q4, ongoing memory-cost pressures, increasing working-capital balances, and the execution and integration of the upcoming RealSense acquisition, alongside consistent dividend growth.
Cognex (NASDAQ: CGNX) reported Q3 2026 revenue of $313.4 million, up 13% year over year, while GAAP diluted EPS rose to $0.50 from $0.10. Record sales, favorable mix, higher volume, pricing execution, and lower operating expenses lifted GAAP operating margin to 32.2% and adjusted EBITDA margin to 35.5%. Free cash flow reached $103.8 million, and Cognex raised its full-year guidance.
Core Financial Results
For the quarter ended October 4, 2026, revenue growth reflected broad-based strength across most major end markets. Excluding the one-time benefit that the Commercial Partnership contributed to Q3 2025, revenue grew 19%; foreign exchange did not have a meaningful effect on consolidated revenue.
Profit increased much faster than sales as gross margin expanded and operating expenses declined. The table separates GAAP results from Cognex’s adjusted, non-GAAP measures.
| Metric | Q3 2026 | Q3 2025 | Year-Over-Year Change |
|---|---|---|---|
| Revenue | $313.4 million | $276.9 million | +13% |
| GAAP gross profit / margin | $221.7 million / 70.8% | $187.3 million / 67.6% | +$34.5 million / +320 bps |
| GAAP operating income / margin | $100.8 million / 32.2% | $57.8 million / 20.9% | +74% / +1,130 bps |
| GAAP net income | $84.8 million | $17.7 million | Up about $67.2 million |
| GAAP diluted EPS | $0.50 | $0.10 | +400% |
| Adjusted diluted EPS | $0.53 | $0.33 | +61% |
| Adjusted EBITDA / margin | $111.4 million / 35.5% | $68.8 million / 24.9% | +61% / +1,060 bps |
| Operating cash flow | $106.4 million | $87.5 million | +22% |
| Free cash flow | $103.8 million | $86.0 million | +21% |
Free cash flow, adjusted EPS, and adjusted EBITDA are non-GAAP measures. Cognex defines free cash flow as operating cash flow less capital expenditures.
Pricing, Mix, and Cost Control Drove Operating Leverage
Adjusted gross margin increased 290 basis points to 71.3%. Cognex attributed the improvement to favorable product mix, higher volume, and faster-than-expected pricing execution, which more than offset memory-cost pressure during the quarter.
GAAP operating expenses fell 7% to $120.9 million, while adjusted operating expenses also declined 7% to $116.5 million. Continued cost management drove the reduction, partly offset by higher sales commissions. Combining lower expenses with higher revenue allowed adjusted EBITDA margin to expand by more than ten percentage points.
The increase in GAAP earnings was also amplified by the prior-year tax comparison. Q3 2025 included a $33.7 million discrete tax expense and a 71.9% GAAP effective tax rate, compared with a 17.9% rate in Q3 2026. Adjusted effective tax rates were much closer at 19.8% and 19.0%, respectively, and adjusted net income rose 61% to $89.8 million. That adjusted increase provides a cleaner view of the underlying earnings improvement than the GAAP net income comparison alone.
Cash Flow and Balance Sheet
Free cash flow represented 122% of GAAP net income and 116% of adjusted net income. Capital expenditures were only $2.6 million, allowing most of the quarter’s operating cash flow to convert into free cash flow.
Cognex ended the quarter with $846 million in cash and investments and no debt. Accounts receivable increased to $216.7 million from $146.7 million at December 31, 2025, while inventory rose to $158.5 million from $137.9 million. Despite those higher working-capital balances, quarterly cash generation remained positive.
The company plans to use existing cash and proceeds from investment sales to fund its all-cash acquisition of RealSense, which is expected to close during Q4 2026. Cognex also paid $14 million in dividends during the quarter and subsequently raised its quarterly dividend by approximately 6% to $0.09 per share.
Guidance
Cognex raised its full-year 2026 revenue, adjusted EBITDA margin, and adjusted EPS ranges. Its new Q4 outlook still indicates year-over-year growth, although the midpoint points to lower revenue and profitability than the record third quarter.
| Period and Metric | Latest Guidance | Previous Guidance or Comparison | Change |
|---|---|---|---|
| Q4 revenue | $270–$290 million | Q4 2025: $252 million | About +11% at midpoint |
| Q4 adjusted EBITDA margin | 29%–32% | Q4 2025: 22.7% | +780 bps at midpoint |
| Q4 adjusted diluted EPS | $0.37–$0.41 | Q4 2025: $0.27 | About +44% at midpoint |
| FY2026 revenue | $1,143–$1,163 million | Prior: $1,130–$1,150 million | Both ends raised by $13 million |
| FY2026 adjusted EBITDA margin | 31%–32% | Prior: 29%–31% | Raised by 1–2 percentage points |
| FY2026 adjusted diluted EPS | $1.68–$1.72 | Prior: $1.64–$1.68 | Both ends raised by $0.04 |
At the Q4 guidance midpoints, revenue would decline about 11% sequentially from Q3, while adjusted EBITDA margin would be approximately 500 basis points lower. Cognex did not provide GAAP reconciliations for the forward adjusted measures because some special items cannot be forecast without unreasonable effort.
Recent Insider Transactions
The supplied insider data include four reported sales and four derivative-security exercises or conversions between May and August 2026. All involved direct ownership; derivative exercises should not be interpreted as open-market purchases.
| Date | Insider | Role | Transaction | Price per Share | Reported Value |
|---|---|---|---|---|---|
| 2026-08-11 | Matthew Moschner | CEO | Sale | $63.61–$65.36 | $1,597,749 |
| 2026-08-11 | Matthew Moschner | CEO | Derivative exercise/conversion | $40.71–$56.44 | $758,984 |
| 2026-05-27 | Darren Marc Long | Officer | Sale | $66.32–$66.52 | $1,343,457 |
| 2026-05-27 | Darren Marc Long | Officer | Derivative exercise/conversion | $49.12–$56.44 | $970,718 |
| 2026-05-12 | Laura Ann MacDonald | Officer | Sale | $65.56–$66.80 | $9,282,195 |
| 2026-05-12 | Laura Ann MacDonald | Officer | Derivative exercise/conversion | $33.04–$56.44 | $6,716,747 |
| 2026-05-11 | Mark Fennell | Officer | Sale | $66.73–$67.08 | $4,349,979 |
| 2026-05-11 | Mark Fennell | Officer | Derivative exercise/conversion | $33.04–$56.44 | $2,720,417 |
These disclosures describe the transactions but do not establish the insiders’ views about Cognex’s future performance.
Risks Investors Need to Watch
- Sequential moderation in Q4: The Q4 revenue midpoint is about 11% below Q3, and the adjusted EBITDA margin midpoint is five percentage points lower. Cognex did not provide a specific reason for the expected sequential decline.
- Memory-cost pressure: Pricing, volume, and favorable mix offset higher memory costs in Q3. A weaker contribution from those offsets could pressure future gross margins.
- RealSense execution: The all-cash acquisition is expected to close in Q4. Closing, integration, and the use of balance-sheet cash create execution and capital-allocation considerations.
- Higher working-capital balances: Receivables and inventory both increased from year-end levels. Cash conversion remained strong in Q3, but investors should monitor whether that performance continues as those balances change.
Summary
Cognex’s Q3 2026 results combined record revenue with substantial operating leverage, supported by broad end-market growth, pricing, favorable mix, and lower expenses. Cash generation remained strong, and management raised full-year guidance. The main items to monitor are the sequential step-down embedded in Q4 guidance, memory-cost pressure, working-capital movements, and the closing and integration of RealSense.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles









Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.